Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Harrie Rila
Cost-Effectiveness of Apixaban Compared to Other Anticoagulants in Patients With Atrial Fibrillation in the Real-World and Trial Settings
PLoS ONE
Multidisciplinary
Related publications
Clinical Outcomes and Cost-Effectiveness of Novel Oral Anticoagulants Incorporating Real-World Elderly Patients With Atrial Fibrillation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of New Oral Anticoagulants Compared With Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin
Circulation. Cardiovascular quality and outcomes
Medicine
Cardiovascular Medicine
Cardiology
Cost-Effectiveness of New Oral Anticoagulants for Patients With Atrial Fibrillation – A Decision Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcv79 - Real-World Cost-Effectiveness of Rivaroxaban Compared With Vitamin K Antagonists in the Context of Stroke Prevention in Atrial Fibrillation in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation
Circulation. Cardiovascular quality and outcomes
Medicine
Cardiovascular Medicine
Cardiology
Cost-Effectiveness Analysis of Apixaban Against Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation in Japan
Clinical Therapeutics
Pharmacology
Pcv108 - Prescribing Choice and the Cost of Anticoagulation in Atrial Fibrillation: A Real World Study Comparing Healthcare Expenditure With Warfarin and Apixaban
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Apixaban for Stroke Prevention in Non-Valvular Atrial Fibrillation in Saudi Arabia
Annals of Saudi Medicine
Medicine
